The ABCD regimen used for Hodgkin’s lymphoma is one that has little impact on fertility. Even if chemotherapy is administered during pregnancy, according to the data (Aviles A, Diaz-Maqueo JC, Talavera A, et al. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol, 1991, 36:243-248.), an analysis of mothers who received chemotherapy for hematologic malignancies (acute and chronic leukemia, Hodgkin’s disease, and non-Hodgkin’s lymphoma) during pregnancy Forty-three children aged 3 to 19 years whose mothers had received chemotherapy during pregnancy for hematologic malignancies (acute and chronic leukemia, Hodgkin’s disease, and non-Hodgkin’s lymphoma) were analyzed. The authors performed a thorough physical examination and neuropsychiatric, hematological, immunological, and cytogenetic examinations of these children without any significant abnormalities. Fourteen of the 43 parturients with Hodgkin’s disease were treated with MOPP (azacitidine, vincristine, methylbenzylhydrazine, prednisone) or ABVD (adriamycin, bleomycin, vincristine, azuremidine) regimens during pregnancy. Five cases received chemotherapy in the first trimester of pregnancy; all five women were 4 to 17 years old at the time of the authors’ report and had no abnormal findings on follow-up examinations. However, the authors claim that the small number of cases is not sufficient to exclude the possibility of teratogenicity of chemotherapy. More information suggests that two years after chemotherapy is more appropriate for pregnancy. Many children with leukemia have grown up to have healthy babies, so you don’t have to worry too much. Besides, there are pregnancy tests! Don’t worry about it! The patient’s good state of mind is more important than anything else! Adjust again to adjust, get married and have a baby!